AHG Akso Health Group

Overview and Growth

Akso Health Group generated $13.83M of revenue in fiscal 2026, with net loss of $18.67M and an operating cash outflow of $12.79M. At $13.83M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 6.4% below fiscal 2025 revenue of $14.78M, marking a top-line contraction. On a per-share basis, diluted EPS was $0.01, which connects the reported earnings outcome with the company’s diluted share count. The per-share result recorded a 93.8% decrease from fiscal 2025 diluted EPS of $0.16. The company employed $189.63M of total assets, the balance-sheet base supporting its current operating and cash-flow results. The revenue-to-assets relationship was 0.07x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

A gross loss of $11.31K left no positive gross-profit layer to absorb operating expenses. Relative to revenue, the gross deficit measured 0.1% before operating expenses. Operations produced a $20.70M operating loss before non-operating and tax effects. Relative to revenue, the operating deficit measured 149.7%, showing the shortfall after operating costs. The bottom-line result was a net loss of $18.67M after operating, financing, tax, and other recognized items. Measured against revenue, the bottom-line deficit represented 135.0% after all recognized items. EBITDA was negative $18.33M, showing a deficit before interest, taxes, depreciation, and amortization. Before income taxes, the company recorded a loss of $20.70M, bridging the operating result to the final net loss. The pretax loss equaled 149.7% of revenue, measuring the pre-tax deficit against sales. The company recognized an income-tax benefit of $1.99M, increasing after-tax earnings relative to the pretax result. The loss-to-equity relationship was 10.3%, placing the bottom-line deficit against shareholder capital. The net loss equaled 9.8% of period-end assets, showing the deficit relative to the asset base. The bottom-line deficit decreased from $134.98M in fiscal 2025 to $18.67M.

Liquidity and Capital Structure

The company held $189.63M of assets against $8.71M of liabilities and $180.92M of equity, revealing how the asset base was financed. Current assets were $189.55M against $8.71M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 21.77x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. The company held $170.57K in cash and equivalents, a narrower liquidity measure than total current assets. Measured only with cash and equivalents, coverage of current liabilities was 2.0%, excluding receivables and other current assets. The equity-to-assets relationship was 95.4%, placing book capital against the total resource base. Relative to total assets, liabilities measured 4.6%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 0.1%, comparing reported cash and equivalents with the full positive asset balance. The asset base changed 11.8% from $214.95M in fiscal 2025, leaving current total assets lower year over year. Against $199.15M of equity in fiscal 2025, the current book-equity balance moved 9.2% and ended lower. The reported cash balance changed 99.9% from $176.23M in fiscal 2025, ending lower year over year.

Cash Flow and Earnings Quality

Cash flow from operations was an outflow of $12.79M, showing that operations absorbed cash during the period. The company spent $1.64K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. Negative free cash flow was $12.79M, leaving a cash deficit after capital spending and reducing financial flexibility. Free-cash-flow margin was -92.5%, reflecting a cash deficit equal to 92.5% of revenue after capital spending. Relative to total assets, the post-investment cash deficit measured 6.7%.

Based on the annual report for the fiscal year ending Mar 31, 2026. Analysis generated Oct 21, 2026.